215 related articles for article (PubMed ID: 27272070)
1. Human Drug Discrimination: Elucidating the Neuropharmacology of Commonly Abused Illicit Drugs.
Bolin BL; Alcorn JL; Reynolds AR; Lile JA; Stoops WW; Rush CR
Curr Top Behav Neurosci; 2018; 39():261-295. PubMed ID: 27272070
[TBL] [Abstract][Full Text] [Related]
2. Human drug discrimination: A primer and methodological review.
Bolin BL; Alcorn JL; Reynolds AR; Lile JA; Rush CR
Exp Clin Psychopharmacol; 2016 Aug; 24(4):214-28. PubMed ID: 27454673
[TBL] [Abstract][Full Text] [Related]
3. JWH-018 and JWH-073: Δ⁹-tetrahydrocannabinol-like discriminative stimulus effects in monkeys.
Ginsburg BC; Schulze DR; Hruba L; McMahon LR
J Pharmacol Exp Ther; 2012 Jan; 340(1):37-45. PubMed ID: 21965552
[TBL] [Abstract][Full Text] [Related]
4. Discriminative Stimulus Properties of Phytocannabinoids, Endocannabinoids, and Synthetic Cannabinoids.
Wiley JL; Owens RA; Lichtman AH
Curr Top Behav Neurosci; 2018; 39():153-173. PubMed ID: 27278640
[TBL] [Abstract][Full Text] [Related]
5. Substitution profile of Delta9-tetrahydrocannabinol, triazolam, hydromorphone, and methylphenidate in humans discriminating Delta9-tetrahydrocannabinol.
Lile JA; Kelly TH; Pinsky DJ; Hays LR
Psychopharmacology (Berl); 2009 Apr; 203(2):241-50. PubMed ID: 19018520
[TBL] [Abstract][Full Text] [Related]
6. The role of human drug self-administration procedures in the development of medications.
Comer SD; Ashworth JB; Foltin RW; Johanson CE; Zacny JP; Walsh SL
Drug Alcohol Depend; 2008 Jul; 96(1-2):1-15. PubMed ID: 18436394
[TBL] [Abstract][Full Text] [Related]
7. Discriminative Stimulus Effects of Psychostimulants.
Berquist MD; Fantegrossi WE
Curr Top Behav Neurosci; 2018; 39():29-49. PubMed ID: 28341944
[TBL] [Abstract][Full Text] [Related]
8. The Discriminative Stimulus Properties of Drugs Used to Treat Depression and Anxiety.
Prus AJ; Porter JH
Curr Top Behav Neurosci; 2018; 39():213-241. PubMed ID: 27352389
[TBL] [Abstract][Full Text] [Related]
9. Clinical neuropharmacology of drugs of abuse: a comparison of drug-discrimination and subject-report measures.
Kelly TH; Stoops WW; Perry AS; Prendergast MA; Rush CR
Behav Cogn Neurosci Rev; 2003 Dec; 2(4):227-60. PubMed ID: 15006288
[TBL] [Abstract][Full Text] [Related]
10. Illicit drug use and violence.
StepjanoviĆ D; Hall W; Leung J
Handb Clin Neurol; 2023; 197():121-145. PubMed ID: 37633705
[TBL] [Abstract][Full Text] [Related]
11. Δ
Rowton SS; Rocha BA; Porter IE
J Pharmacol Toxicol Methods; 2020; 106():106937. PubMed ID: 33096236
[TBL] [Abstract][Full Text] [Related]
12. The Discriminative Stimulus Properties of Hallucinogenic and Dissociative Anesthetic Drugs.
Mori T; Suzuki T
Curr Top Behav Neurosci; 2018; 39():141-152. PubMed ID: 27586539
[TBL] [Abstract][Full Text] [Related]
13. Relationship between drug discrimination and ratings of subjective effects: implications for assessing and understanding the abuse potential of D-amphetamine in humans.
Reynolds AR; Bolin BL; Stoops WW; Rush CR
Behav Pharmacol; 2013 Sep; 24(5-6):523-32. PubMed ID: 23851485
[TBL] [Abstract][Full Text] [Related]
14. Drug discrimination: A versatile tool for characterization of CNS safety pharmacology and potential for drug abuse.
Swedberg MD
J Pharmacol Toxicol Methods; 2016; 81():295-305. PubMed ID: 27235786
[TBL] [Abstract][Full Text] [Related]
15. Separate and combined effects of the GABA(B) agonist baclofen and Δ9-THC in humans discriminating Δ9-THC.
Lile JA; Kelly TH; Hays LR
Drug Alcohol Depend; 2012 Nov; 126(1-2):216-23. PubMed ID: 22699093
[TBL] [Abstract][Full Text] [Related]
16. Drug Discrimination: Historical Origins, Important Concepts, and Principles.
Porter JH; Prus AJ; Overton DA
Curr Top Behav Neurosci; 2018; 39():3-26. PubMed ID: 29637526
[TBL] [Abstract][Full Text] [Related]
17. Differential drug-drug interactions of the synthetic Cannabinoids JWH-018 and JWH-073: implications for drug abuse liability and pain therapy.
Brents LK; Zimmerman SM; Saffell AR; Prather PL; Fantegrossi WE
J Pharmacol Exp Ther; 2013 Sep; 346(3):350-61. PubMed ID: 23801678
[TBL] [Abstract][Full Text] [Related]
18. Snapshot of narcotic drugs and psychoactive substances in Kuwait: analysis of illicit drugs use in Kuwait from 2015 to 2018.
Al-Matrouk A; Al-Hasan M; Naqi H; Al-Abkal N; Mohammed H; Haider M; Al-Shammeri D; Bojbarah H
BMC Public Health; 2021 Apr; 21(1):671. PubMed ID: 33827491
[TBL] [Abstract][Full Text] [Related]
19. Discriminative stimulus effects of the GABAB receptor-positive modulator rac-BHFF: comparison with GABAB receptor agonists and drugs of abuse.
Koek W; Cheng K; Rice KC
J Pharmacol Exp Ther; 2013 Mar; 344(3):553-60. PubMed ID: 23275067
[TBL] [Abstract][Full Text] [Related]
20. The discriminative stimulus effects of midazolam are resistant to modulation by morphine, amphetamine, dizocilpine, and γ-butyrolactone in rhesus monkeys.
Bai X; France CP; Gerak LR
Psychopharmacology (Berl); 2011 Oct; 217(4):495-504. PubMed ID: 21503606
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
